ASTAGRAF XL .5 mg/1
tacrolimus extended-release capsules · CAPSULE, COATED, EXTENDED RELEASE · Astellas Pharma US, Inc.
ASTAGRAF XL is a capsule, coated, extended release containing tacrolimus extended-release capsules at .5 mg/1, taken oral. Manufactured by Astellas Pharma US, Inc..
Key Facts
- Brand Name
- ASTAGRAF XL
- Generic Name
- tacrolimus extended-release capsules
- NDC Code (Product)
0469-0647- Manufacturer
- Astellas Pharma US, Inc.
- Strength
- .5 mg/1
- Dosage Form
- CAPSULE, COATED, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA204096
- Marketing Start
- 07/19/2013
Recall History
Astellas Pharma US Inc.
Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
Side Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is ASTAGRAF XL used for?
ASTAGRAF XL contains tacrolimus extended-release capsules. It is a capsule, coated, extended release taken oral. Consult your doctor for specific uses.
Is ASTAGRAF XL a controlled substance?
ASTAGRAF XL is not classified as a controlled substance by the DEA.
What is the generic name for ASTAGRAF XL?
The generic name for ASTAGRAF XL is tacrolimus extended-release capsules. There are 3 other brand versions of tacrolimus extended-release capsules.
What is the NDC code for ASTAGRAF XL .5 mg/1?
The NDC (National Drug Code) for ASTAGRAF XL .5 mg/1 is 0469-0647, listed by Astellas Pharma US, Inc..